[Microorganisms and coronary heart disease. Do antibiotics protect against cardiac events?].
Jahn
J
J
Oberarzt Kardiologie, Borromäus-Hospital, Leer. jahn@borro-leer.de
Dalhoff
K
K
Richardt
G
G
D042462:4-Quinolones; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D016022:Case-Control Studies; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy* / Q000209:etiology* / Q000517:prevention & control; D005500:Follow-Up Studies; D006801:Humans; D007239:Infections / Q000150:complications* / Q000188:drug therapy; D009203:Myocardial Infarction / Q000209:etiology / Q000517:prevention & control; D010919:Placebos; D012141:Respiratory Tract Infections / Q000150:complications; D012959:Socioeconomic Factors; D013754:Tetracyclines / Q000627:therapeutic use; D013997:Time Factors; D014552:Urinary Tract Infections / Q000150:complications
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D010919:Placebos; D013754:Tetracyclines